Alterations to hormones, chronic inflammation, and increased pathological fat distribution disturb insulin sensitivity and glucose metabolism, which further emphasizes that metabolic dysfunction is a hallmark of T2DM. The gene discussed is INS; the disease is type 2 diabetes mellitus.